BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 17, 2026
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
July 8, 2013
View Archived Issues
An Advance Worth Drinking To: Functional, if still tiny, human liver created from stem cells
Starting with induced pluripotent stem cells (iPSCs), scientists have created the first artificial organ – a functional liver bud, which is the precursor to the mature liver that is normally formed early in embryonic development.
Read More
TMS seeks to improve monitoring in ICU via variability analysis
Read More
Researchers develop telescope-like contact lens for AMD patients
Read More
Washington roundup: AMA urges obesity-as-disease approach; BMI as Dx an issue
Read More
Financings roundup: GI Dynamics completes its $57.5M private placement
Read More
International report: Guided Therapeutics to place LuViva in Turkey
Read More
Agreements/contracts: OptiNose to deliver Avanir's sumatriptan
Read More
HIT roundup: Washington hospital launches WeCare EHR system from Epic
Read More
Court report: Baxano reaches final agreement with DoJ regarding subpoena
Read More
Holiday Notice
Read More
Product Briefs
Read More
Med-Tech Notes
Read More
People in the News
Read More
MDD's Neurology Extra
Read More
MDD's Financial Roundup (Q213) Deals roundup: Device firms report/close 15 deals in 2Q13 worth $29B
Read More
Financings roundup: Second quarter sees drop off compared to first part of 2013
Read More
Washington roundup: SCOTUS says no to isolated DNA, but cDNA still eligible
Read More
Agreements/contracts: Numbers drop a little; but innovation, and coverage, continues
Read More
